TGTX
TG THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$61.63
+1.45%Forward multiples
Based on analyst estimates
- P/E forward
- 26.90x
- P/E 2026E
- 61.98x
- P/E 2027E
- 21.56x
- P/E 2028E
- 16.75x
- P/S forward
- 7.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.24x
- PEG TTM
- —
- Price / book
- 15.62x
- Price / sales
- 11.80x
- Price / cash flow
- 527.73x
Enterprise value
- Enterprise value
- $9.6B
- EV / sales
- 12.05x
- EV / EBITDA
- 71.77x
- EV / EBIT
- 70.68x
- Market cap
- $9.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026